Humacyte, Inc.(HUMA)

Biotechnology company.

6 Insights

Investment Insights

AI-generated insights about Humacyte, Inc. from various financial sources

Wednesday, November 12, 2025

Very Bearish

The speaker is bearish and was shorting the stock, highlighting a significant valuation concern where the company generated only $700k in revenue with a market cap of around $250 million.

Martin Shkreli
11/12/25 +516%
Martin ShkreliYouTube178 days ago

Tuesday, October 28, 2025

Very Bearish

The speaker is bearish, mocking the company for an 'oversubscribed deal for warrants' and suggesting it's a sign of weakness.

Martin Shkreli
10/28/25 +331%
Martin ShkreliYouTube193 days ago

Thursday, August 21, 2025

Very Bearish

The CEO made a large, unscheduled sale of $3.7 million. Following the CEO's previous sales, the stock has fallen an average of 15%.

Wednesday, August 13, 2025

Very Bearish

Mentioned as a potential short idea due to low revenue.

Martin Shkreli
8/13/25 +25%
Martin ShkreliYouTube268 days ago

Monday, August 11, 2025

Very Bearish

The speaker is extremely bearish, calling the company a 'dog' and a 'whole disaster.' This is due to extremely weak revenue ('less than a million'), with no reason seen for the stock to rebound.

Martin Shkreli
8/11/25 +25%
Martin ShkreliYouTube270 days ago

Tuesday, July 29, 2025

Bearish

Listed as one of the speaker's biggest losing positions, which came from a short position he was holding.